Procept Biorobotics CorpPRCT
Mentioned
Impact on assets 2
Robotics & Physical AI▲ · 2 stocks
Procept Biorobotics Corp
Stryker CorporationSYK
Mentioned
Theme Impact 1
Off-coverage companies
Related news
▲3
Intuitive Surgical Wins World-First CE Mark for da Vinci SP Transvaginal Surgery
Intuitive Surgical received CE mark approval earlier this month for using its da Vinci SP single-port robotic system in transvaginal gynecologic procedures, a world-first indication for the SP platform that adds to its existing European approvals for a range of endoscopic and natural-orifice surgeries. The approval broadens the SP system's clinically supported use in complex anatomical spaces and deepens the company's position in minimally invasive, scarless surgery. The new indication is unlikely to shift near-term catalysts in a major way, as Intuitive Surgical continues to manage multiple Class II recalls, execute on its ambulatory surgery center push, and justify a rich earnings multiple after a sharp year-to-date share price pullback. Eleven fair value views from the Simply Wall St Community range from about US$324 to over US$630 per share, underscoring how differently investors frame the company's prospects.
DePuy Synthes Unveils Four New VOLT Plating Systems and MAXFRAME AUTOSTRUT at OTA 2026
DePuy Synthes is showcasing its latest trauma innovations at the 2026 Orthopaedic Trauma Association Annual Meeting in Nashville, including four new VOLT plating systems, the MAXFRAME AUTOSTRUT with Bluetooth Multi-Axial Correction System, VELYS Trauma AI Assisted Surgery, and an expanded procedural solutions offering. The four new plating systems expand the company's flagship VOLT fracture fixation platform across the ankle, knee, and shoulder, extending its anatomic plating portfolio into some of the most common and clinically demanding fracture procedures. The MAXFRAME AUTOSTRUT with Bluetooth Multi-Axial Correction System is now commercially available in the U.S. and is described as the first and only system to combine fully automated device adjustments with real-time remote monitoring and treatment management for complex limb reconstruction. VELYS Trauma AI-Assisted Surgery, which delivers intraoperative surgical guidance and fracture reduction assistance with precise 3D guidance without trackers or reference bodies, is launching in the U.S. in 2027. The company is also expanding its trauma commercial portfolio to include a comprehensive soft tissue portfolio featuring DYNACORD, GRYPHON, SUPERHAWK, and HEALIX Anchor technologies, and will offer interactive demos of its SOURCEVIEW Analytics Platform. Paolo Di Vincenzo, Global President of Trauma at DePuy Synthes, said an estimated 178 million new fractures occur globally each year and that the company is expanding into connected care across the entire skeleton.
▲
Intuitive Surgical Targets ASCs With Refurbished XiR Robots
Intuitive Surgical is making ambulatory surgery centers its new growth engine, placing 27 da Vinci systems at U.S. ASCs in the second quarter, 20 of them refurbished XiR platforms priced below the flagship model. Management said the increase reflected its recent focus on the ASC segment and described the placements as part of broader greenfield expansion. About 130 XiR systems were installed globally over the past year, with approximately 50 in the United States, and management said XiR has been particularly attractive to ASCs and smaller hospitals while gaining traction internationally. Intuitive Surgical also plans to introduce extended-use EndoWrist instruments in 2027, targeting lower cost per procedure in high-volume benign procedures. Among peers, Stryker is positioning its orthopedic and MedSurg portfolio for the ASC shift and plans to ramp up Mako RPS commercialization, while Zimmer Biomet is emphasizing efficiency, noting implants account for only about 14-15% of ASC costs. Intuitive Surgical shares have lost 30.6% so far this year, and the stock carries a Zacks Rank #3 (Hold).